Hepatitis B in liver transplant recipients as a special model of antiviral drug development.
Gish
Robert G
RG
Department of Transplantation, California Pacific Medical Center, San Francisco, USA.
Wakil
Adil
A
D000284:Administration, Oral; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006509:Hepatitis B / Q000188:drug therapy*; D017325:Hepatitis B Vaccines / Q000008:administration & dosage; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007372:Interferons / Q000627:therapeutic use; D016031:Liver Transplantation; D014019:Tissue Donors
D000998:Antiviral Agents; D017325:Hepatitis B Vaccines; D007166:Immunosuppressive Agents; D007372:Interferons